| Mar 24 | Mar 23 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | ||
| Gross Profit | $ 410.00 | - |
| Operating Income | $ -114.24K | $ -270.65K |
| EBITDA | $ -146.95K | $ -265.61K |
| Net Income | $ -146.95K | $ -265.61K |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ ― | $ ― |
| Total Assets | $ 153.72K | $ 302.54K |
| Total Debt | $ 0.00 | $ 0.00 |
| Net Debt | $ -148.99K | $ -261.97K |
| Total Liabilities | $ 21.97K | $ 38.97K |
| Stockholders' Equity | $ ― | $ ― |
| Cash Flow | ||
| Free Cash Flow | ||
| Operating Cash Flow | $ -112.98K | $ -271.55K |
| Investing Cash Flow | ||
| Financing Cash Flow |
Adaptogenics Health Corp. (TSE:ADPT)
:ADPT
